Analysis of mutant K-ras in multiple sites of normal appearing mucosa of colorectal cancer patients

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 911-915

  Minamoto, Toshinari ^a,b   Yamashita, Naoyuki ^c   Ochiai, Atsushi ^c   Mai, Masayoshi ^b   Sugimura, Takashi ^c   Ronai, Zeev ^a   Esumi, Hiroyasu ^c  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

biomarker; colorectal cancer; K ras; mutation; non neoplastic mucosa

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; PRIORITY JOURNAL;

EID: 0029860391     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.5.911     Document Type: Article

References (30)

1. Weinberg RA: Oncogenes, antioncogenes and the molecular bases of multistep carcinogenesis. Cancer Res 49: 3713-3721, 1991.
2. Hunter T: Cooperation between oncogenes. Cell 64: 249-272, 1991.
3. Kumar R, Sukumar S and Barbacid M: Activation of ras oncogenes preceding the onset of neoplasia. Science 248: 1101-1104, 1990.
4. Ronai Z, Lau Y and Cohen L: Dietary N-3 fatty acids do not affect induction of H-ras mutations in mammary glands of NMU treated rats. Mol Carcinog 4: 120-128, 1991.
5. Jacoby RF, Llor X, Teng B, Davidson NO and Brasitus TA: Mutations in K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest 87: 624-630, 1991.
6. Nikitin AU, Ballering LAP, Lyons J and Rajewsky MF: Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci USA 88: 9939-9943, 1991.
7. Junis JJ, Boot AJM, Mayer MG and Bos JL: Mechanism of ras mutation in myelodysplastic syndrome. Oncogene 4: 609-614, 1989.
8. Wong L-D, Hong J-Y, Qiu S-L, Gao H and Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis. Cancer Res 53: 1783-1787, 1993.
9. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK and Hittelman WN: Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54: 321-326, 1994.
10. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK and Yamasaki H: UV and skin cancer: Specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 91: 360-364, 1994.
11. Bos JL: ras oncogene in human cancer: A review. Cancer Res 49: 4682-4689, 1989.
12. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
13. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
14. Kahn SM, Jiang W, Culbertson TA, Weinstein IB, Williams GM, Tomita N and Ronai Z: Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene 6: 1079-1083, 1991.
15. Minamoto T, Ronai Z, Yamashita N, Ochiai A, Sugimura T, Mai M and Esumi H: Detection of Ki-ras mutation in non-neoplastic mucosa of Japanese patients with colorectal cancers. Int J Oncol 4: 397-401, 1994.
16. Ronai Z, Luo FC, Gradia S, Hart WJ and Butler R: Detection of K-ras mutation in normal and malignant colonic tissues by an Enriched PCR method. Int J Oncol 4: 391-396, 1994.
17. Jiang W, Kahn SM, Guillem JG, Lu S-H and Weinstein IB:. Rapid detection of ras oncogenes in human tissues: applications to colon, esophageal, and gastric cancer. Oncogene 4: 923-928, 1989.
18. Capon DJ, Seeburg PH, McGrath JP, Hayflick JS, Edman U, Levinson A and Goeddel DV: Activation of Ki-ras 2 gene in human colon and lung carcinomas by two different point mutations. Nature 304: 507-513, 1983.
19. Suzuki Y, Sekiya T and Hayashi K: Allele-specific polymerase chain reaction: A method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 192: 82-84, 1991.
20. Gyllensten UB and Erlich HA: Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 85: 7652-7656, 1988.
21. Japanese Research Society for Cancer of the Colon and Rectum: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Part II. Histopathological classification. Jpn J Surg 13: 557-598, 1983.
22. Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Peterson G, Hamilton SR, Kinzler KW, Vogelstein B and Nakamura Y: Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89: 4452-4456, 1992.
23. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C and Kaplan EL: K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 85: 2004-2007, 1993.
24. Yamashita N, Minamoto T, Ohiai A, Onda M and Esumi H: Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 108: 434-440, 1995.
25. Roncucci L, Stamp D, Medline M, Cullen JB and Bruce WR: Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22: 287-294, 1991.
26. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA and Stellato TA: Aberrant crypts: Putative preneoplastic foci in human colonic mucosa. Cancer Res 51: 1564-1567, 1991.
27. Fearon ER: K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer. J Natl Cancer Inst 85: 1978-1980, 1993.
28. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992.
29. Ronai Z, Minamoto T, Butler R, Tobi M, Luo F-Q, Zang E, Esumi H and Sugimura T: Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions. Cancer Detec Prev 19: 512-517, 1995.
30. Tobi M, Luo FC and Ronai Z: Detection of K-ras mutantion in colonic effluent samples from patients without evidence of colorectal carcinoma. J Natl Cancer Inst 86: 1007-1010, 1994.